Stocks sink on new COVID variant; Dow loses 1,000 points

(Photo by Spencer Platt/Getty Images)

Stocks fell sharply Friday, with the Dow Jones Industrial Average down more than 1,000 points, as a new coronavirus variant from South Africa appeared to be spreading across the globe. It added to investor uncertainty about potentially reversing months of progress at getting the COVID-19 pandemic under control.

Health officials in Europe and the U.K. moved quickly to propose suspending air travel from southern Africa. Meanwhile cases of the variant were found in Hong Kong, Belgium and Tel Aviv as well as major South African cities like Johannesburg.

MORE: South African scientists identify new COVID-19 variant

The blue chips were down 1,050 points by late morning to 34,792. The S&P 500 index was down 2.3%, on pace for its worst day since February. The Nasdaq Composite was down 2.2%.

There have been other variants of the coronavirus before — the delta variant devastated much of the U.S. throughout the summer — and investors, public officials and the general public are jittery about any new variant that’s spreading. It’s been nearly two years since COVID-19 emerged, which has killed more than 5 million people around the globe.

"Investors are likely to shoot first and ask questions later until more is known," Jeffrey Halley of Oanda said in a report. That was evident from the action in the bond market, where the yield on the 10-year U.S. Treasury note fell to 1.51% from 1.64% on Wednesday. The bond market was closed Thursday in the U.S. for Thanksgiving.

RELATED: South Africa variant: WHO calls special meeting new COVID-19 mutation

The economic impacts of this variant are already being felt. Flights between South Africa and Europe were being subject to quarantine or being shut down altogether. Airline stocks were quickly sold off, with Delta Air Lines, United Airlines and American Airlines falling more than 10% each.

Oil prices also fell sharply, plunging nearly 12%.

A sign of how fearful Wall Street has become was the VIX, the market’s measurement of volatility that is sometimes referred to as the market’s "fear gauge." The VIX jumped 48% to a reading of 26.91, its highest reading since January before the vaccines began to be widely distributed.

Fearful of more lockdowns and travel bans, investors moved money into companies that largely benefited from previous waves, like Zoom Communications for meetings or Peloton for at-home exercise equipment. Peloton shares were up 5% while Zoom was up roughly 7%.

Shares in the coronavirus vaccine manufacturers were among the biggest gainers as well. Pfizer shares rose nearly 6% while Modern shares jumped 23%.

Merck shares were down 4%, however. While U.S. health officials said Merck’s experimental treatment of COVID-19 was effective, data showed the pill was not as effective at keeping patients out of the hospital as originally thought in the data.

Investors are worried that the supply chain issues that have impacted global markets for months will worsen. Ports and freight yards are vulnerable and could be shut by new, localized outbreaks.

RELATED: Consumer shortages offer supply-chain lessons

"Supply chains are already stretched," said Neil Shearing, an economist with Capital Economics in London. "A new, more dangerous, virus wave could cause some workers to temporarily exit the workforce, and deter others from returning, making current labor shortages worse.’’

The variant also puts more pressure on central banks, who already faced with a tough dilemma: whether and when to raise interest rates to combat rising inflation. "The threat of a new, more serious, variant of the virus may be a reason for central banks to postpone plans to raise interest rates until the picture becomes clearer," Shearing said.

Stock trading the Friday after Thanksgiving is typically the slowest day of the year, with the market closing at 1 p.m. Eastern. The light trading could exacerbate any of Friday’s losses with fewer buyers and sellers.

CLICK HERE FOR MORE ON THE STOCK MARKET

Stock MarketNewsCoronavirusMoney